Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence
Open accessThe DOI matches its Crossref record; 113 of the 114 references it cites were found in a registry or an index; 27 of the 139 sources its claims cite were checked for support.
Abstract
Genetic recombination in RNA viruses was discovered many years ago for poliovirus (PV), an enterovirus of the Picornaviridae family, and studied using PV or other picornaviruses as models. Recently, recombination was shown to be a general phenomenon between different types of enteroviruses of the same species. In particular, the interest for this mechanism of genetic plasticity was renewed with the emergence of pathogenic recombinant circulating vaccine-derived polioviruses (cVDPVs), which were implicated in poliomyelitis outbreaks in several regions of the world with insufficient vaccination coverage. Most of these cVDPVs had mosaic genomes constituted of mutated poliovaccine capsid sequences and part or all of the non-structural sequences from other human enteroviruses of species C (HEV-C), in particular coxsackie A viruses. A study in Madagascar showed that recombinant cVDPVs had been co-circulating in a small population of children with many different HEV-C types. This viral ecosystem showed a surprising and extensive biodiversity associated to several types and recombinant genotypes, indicating that intertypic genetic recombination was not only a mechanism of evolution for HEV-C, but an usual mode of genetic plasticity shaping viral diversity. Results suggested that recombination may be, in conjunction with mutations, implicated in the phenotypic diversity of enterovirus strains and in the emergence of new pathogenic strains. Nevertheless, little is known about the rules and mechanisms which govern genetic exchanges between HEV-C types, as well as about the importance of intertypic recombination in generating phenotypic variation. This review summarizes our current knowledge of the mechanisms of evolution of PV, in particular recombination events leading to the emergence of recombinant cVDPVs.
Overview
CoChat Summary
## TL;DR
This review argues that poliovirus evolution is shaped by frequent mutation and recombination, and that circulating vaccine-derived polioviruses (cVDPVs) are a major consequence of this plasticity. It highlights that most cVDPVs are mosaics of Sabin vaccine capsid sequences plus non-structural regions from other human enteroviruses species C (HEV-C), especially coxsackie A viruses, and that this recombination can help explain outbreaks in under-immunized populations.
## Key findings
- In the 2000–2001 Hispaniola outbreak, 21 confirmed acute flaccid paralysis (AFP) cases were reported: 13 in the Dominican Republic and 8 in Haiti, including 2 fatal cases; affected communities had trivalent OPV coverage of 7%–40%.
- In Madagascar, a 2001–2002 outbreak produced 5 AFP cases; the urban isolates were about 1% divergent from Sabin 2 in VP1, while rural isolates were about 2.5% divergent, and sequencing showed two independent recombinant cVDPV lineages.
- In Nigeria, a severe type 2 cVDPV outbreak lasted more than six years and involved more than 300 cases; in general, studied cVDPV VP1 sequences diverged from parental OPV strains by 1%–3.5%, and in Nigeria divergence reached up to 6%.
- The paper states that the first cVDPV outbreaks showed 21 confirmed cases in Hispaniola, 3 cases in the Philippines, 30 cases in Egypt, and 5 cases in Madagascar (2005 outbreak), with most outbreak strains being PV/HEV-C recombinants.
## Methods
- This is a review article, not an original experimental study; it synthesizes prior virology, epidemiology, and molecular genetics studies on poliovirus recombination and cVDPVs.
- It draws on sequence comparisons, outbreak investigations, and prior engineered recombinant/chimeric virus experiments in cells and mice, including transgenic mice expressing the human PV receptor CD155.
- It summarizes analyses such as VP1 sequence divergence, full-genome sequencing, RFLP, and phylogenetic/partial sequencing of isolates from patients, contacts, sewage, and healthy children.
## Limitations
- The paper explicitly states that little is known about the rules and mechanisms governing genetic exchange between HEV-C types, the importance of intertypic recombination in phenotypic variation, and the factors underlying co-infection and selection of recombinants.
- It also says the role of genetic exchanges in the characteristics of OPV/HEV-C recombinants is still unclear.
- Evident from the text: because this is a narrative review, it does not present a single unified dataset or a new experimental design; many conclusions are based on previously reported cases and studies rather than primary data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2. Reported poliomyelitis outbreaks due to circulating vaccine-derived polioviruses (cVDPVs) (since 1988). The country, the type of implicated cVDPVs, the year of the outbreak and the number of reported cases are indicated. Data are those available from WHO/HQ on 3 May 2011 [11].](https://figures.cochat.ai/paper-figures/ade2631ac4394f3f9331215fc085f158/recombination-between-poliovirus-and-coxsackie-a-viruses-of-species-c-a-model-of-figure-2.jpg)
![Figure 3. Genetic features of recombinant genomes from cVDPVs implicated in different outbreaks. A schematic view of the genetic organization of the poliovirus genome is given (see also Figure 1). The presence of vaccine-derived sequences are indicated above the cVDPV genomes (mutated Sabin 1 or 2 sequences) as well as the non-vaccine sequences derived from other HEV-Cs (HEV-C sequences). Patterns differentiate HEV-C sequences that differed significantly from each other. Data are modified from [83] (Hispaniola), [84] (Philippines), [67] (Egypt) and [85] (Nigeria).](https://figures.cochat.ai/paper-figures/ca99ef76feff456793c1e9bd31e5d988/recombination-between-poliovirus-and-coxsackie-a-viruses-of-species-c-a-model-of-figure-3.jpg)
![Figure 4. Genetic features of recombinant cVDPV genomes from Madagascar. Some cVDPVs isolated in Madagascar in 2002 and 2005 are represented as in Figure 3. Non-vaccine sequences (HEV-C sequences) showing similarity with those of coxsackie A viruses (CV-A11, -A13, -A17) isolated in the same province are indicated. Data are modified from [88–90].](https://figures.cochat.ai/paper-figures/37a10338ee294b898fc03da6944f1836/recombination-between-poliovirus-and-coxsackie-a-viruses-of-species-c-a-model-of-figure-4.jpg)
Verification
Claims the paper makes
20 Valid · 2 Not valid · 49 Not checked · 18 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, the capsid-encoding region, with a rate of fixation of total substitutions in the order of 10−2 substitutions/site/year, appears less genetically stable than the region encoding non-structural proteins [17,18].”
§ Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence > Poliovirus Evolution by Mutation and Recombination
What the sources say
- Partly supportedcites [17] Jorba, 2008, Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range, J. Virol. sourceExperimental — accuracy not yet measured
Our copy fully supports the quantitative half of the claim: the Abstract states that 'estimates of the rates of total nucleotide substitution into poliovirus capsid regions average ~10^-2 substitutions per site per year', and the Results (Table 3) give the calibrated Kt clock for the P1/capsid region as (1.03 +/- 0.10) x 10^-2 substitutions/site/year. However, the paper is confined to the P1/capsid region and contains no comparison of genetic stability or substitution rate between the capsid-encoding region and the non-structural (P2/P3) protein-coding region; the only statements about noncapsid regions (Discussion, p. n/a) concern frequent recombination in P2/P3 and the 5'-UTR distorting molecular clocks, and the Discussion instead notes the capsid Kt rate is 'among the highest reported for any RNA virus'. The comparative clause 'less genetically stable than the region encoding non-structural proteins' is therefore not supported by this source. (LLM, conf=0.80)
- Not checked yetcites [18] Blomqvist, 2010, Mechanisms of genetic variation in polioviruses, Rev. Med. Virol. source
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, it has been only recently shown that the recombination of PV with other enteroviruses can be the source of new PV strain emergence [3].”
§ Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence > Poliovirus and Poliomyelitis: Successes and Recent Hurdles in Eradication
What the sources say
- Supportedcites [3] Kew, 2005, Vaccine-derived polioviruses and the endgame strategy for global polio eradication, Annu. Rev. Microbiol. source
The 'Polioviruses' section states that only the capsid-encoding sequences are unique to polioviruses, 'as the flanking sequences are frequently exchanged by recombination with the closely related species C enteroviruses during circulation in nature,' and the evolution section adds that 'Polioviruses actively recombine with each other ... and with the closely related species C human enteroviruses,' with recombination junctions serving as markers for resolving poliovirus lineages. The 'Recombination with species C enteroviruses (cVDPVs)' passage shows the concrete consequence: all cVDPV isolates from Egypt, Hispaniola, Madagascar and the Philippines were vaccine/nonvaccine recombinants acquiring noncapsid sequences from nonvaccine species C NPEVs, with serial recombination generating 4 recombinants in Hispaniola and 22 noncapsid plus 2 5'-UTR recombinants in Egypt. That is recombination with other enteroviruses as a source of new poliovirus strains/lineages; the paper's caveat that recombination 'may not be essential to the phenotypic reversion of OPV' concerns reversion, not the ability of recombination to generate new strains, so it does not contradict the hedged claim. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Sequencing of the cVDPV genomes confirmed the presence of two independent recombinant cVDPV lineages with most of the 3′ half of the genomes derived from HEV-C species [88].”
§ Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence > Circulating Vaccine-Derived Polioviruses Implicated in Polio Outbreaks
What the sources say
- Supportedcites [88] Rakoto-Andrianarivelo, M., Guillot, S., Iber, J., Balanant, J., Blondel, B., Riquet, F., Martin, J., Kew, O., Randriamanalina, B., and Razafinimpiasa, L. (2007). Co-circulation and evolution of polioviruses and species c enteroviruses in a district of madagascar. PLoS. Pathog., 3. source
The Abstract states the Madagascan VDPVs 'appeared to belong to two independent recombinant lineages with sequences from the type 2 strain of the oral poliovaccine (OPV) in the 5′-half of the genome and sequences derived from unidentified species C enteroviruses (HEV-C) in the 3′-half'. The Results (Sequence Analysis of the Madagascan VDPV Genomes) confirm this from the sequencing itself: the 3′-halves of MAD 04 and MAD 29 diverged from Sabin 2 by 12.9–16.5% nt, recombination junctions lay in the 2A protease region (~nt 3,801 and ~nt 3,708), and the two isolates 'represented two different recombinant VDPV lineages that had emerged and evolved independently'. The Discussion further ties the 3′-region sequences to co-circulating CA17 (2C) and CA13 (3D) HEV-C isolates; the only wording shift is the citing paper's 'cVDPV' label, while this paper writes 'VDPV' (it does document prolonged circulation of the MAD 04 lineage). (LLM, conf=0.90)
plainn = 5- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Another outbreak, due to type 2 cVDPVs, was reported retrospectively in Egypt following the analysis of type 2 PV strains that were thought to be one of the last circulating wild type 2 strains [67].”
§ Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence > Circulating Vaccine-Derived Polioviruses Implicated in Polio Outbreaks
What the sources say
- Supportedcites [67] Yang, 2003, Circulation of endemic type 2 vaccine-derived poliovirus in egypt from 1983 to 1993, J. Virol. source
The Abstract (p. 1) states that from 1988 to 1993, 30 type 2 poliomyelitis cases in seven Egyptian governorates were initially assumed to signal continued circulation of wild type 2 poliovirus, and that VP1 comparison of those case isolates later revealed them to be 93–97% identical to Sabin 2 and <82% identical to the previously indigenous wild type 2 viruses — i.e., a retrospective genetic analysis establishing a type 2 cVDPV outbreak. The RESULTS section repeats this ('it was assumed at the time that these cases signaled the continued circulation of the indigenous wild poliovirus type 2'), and the DISCUSSION explicitly calls Egypt one of 'the outbreaks … associated with type 2 cVDPV'. The only mild wording shift is 'one of the last circulating wild type 2 strains' for the paper's 'continued circulation of the indigenous wild type 2 poliovirus' (last characterized Egyptian wild type 2 isolate: 1979), which is equivalent in substance. (LLM, conf=0.90)
plainn = 30- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“More recently it was shown that a direct interaction between the non-structural protein 2C and the capsid protein VP3 is required for enterovirus morphogenesis [112].”
§ Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence > Impact of Non-PV Sequences on the Characteristics of cVDPVs—in vitro-Made Recombinants
What the sources say
- Supportedcites [112] Liu, Y., Wang, C., Mueller, S., Paul, A.V., Wimmer, E., and Jiang, P. (2010). Direct interaction between two viral proteins, the nonstructural protein 2c and the capsid protein vp3, is required for enterovirus morphogenesis. PLoS. Pathog., 6. source
The paper's title and Abstract state exactly this: the direct 2C ATPase–VP3 interaction is required for enterovirus morphogenesis/encapsidation, with the Abstract noting the mechanism rests on 2C ATPase having specific affinity for capsid protein(s) and that a PV/CAV20 protein mismatch yielded non-virions. The Results/Discussion section 'A direct interaction between proteins 2C ATPase and VP3 is revealed by biochemical assays' states 'The data support our hypothesis that 2C ATPase is required for viral encapsidation through a direct interaction with capsid protein VP3' and that 'sufficient protein-protein interaction between 2C ATPase and VP3 is essential for the encapsidation process'. 2C here is the nonstructural 2C ATPase and VP3 the capsid protein, in enteroviruses (poliovirus, coxsackievirus A20), matching the paraphrase. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
46 more claims · 10 with their cited sources checked
Create a free account to see all 89 claims and to verify the 112 references still open.
- It may state two separate claims as one. 35
- Probably not a substantial claim. 5
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“les déterminants majeurs de l'atténuation des souches vaccinales Sabin, qui se trouvent dans la région 5' non codante et affectent l'efficacité de la traduction, ont subi, chez les cPVDV, des réversions vers le génotype sauvage [13, 15, 20].”
From Éradication de la poliomyélite et émergence de poliovirus pathogènes dérivés du vaccin: De Madagascar au Cameroun (2013) · cites this paper as [20]
In the citing paper
“un écosystème caractérisé par une fréquence et une diversité élevées des HEV-C, notamment les CVA-13 et CVA-17, créerait des conditions particulièrement favorables à l'émergence et à la circulation des souches de cPVDV recombinantes pathogènes [20].”
From Éradication de la poliomyélite et émergence de poliovirus pathogènes dérivés du vaccin: De Madagascar au Cameroun (2013) · cites this paper as [20]
In the citing paper
“suggérant fortement un rôle de la recombinaison entre PV et CVA de la même espèce, dans l'émergence des cPVDV [4, 20].”
From Éradication de la poliomyélite et émergence de poliovirus pathogènes dérivés du vaccin: De Madagascar au Cameroun (2013) · cites this paper as [20]
In the citing paper
“les études menées à Madagascar, au Cameroun, et dans les autres pays du REIP, en étroite collaboration avec l'Institut Pasteur de Paris, ont montré la parenté entre certaines séquences du génome des cPVDV et celles de souches locales de CVA de la même espèce, en particulier les CVA-17 et CVA-13”
From Éradication de la poliomyélite et émergence de poliovirus pathogènes dérivés du vaccin: De Madagascar au Cameroun (2013) · cites this paper as [20]
Citations
Cites
Vignuzzi, M., Stone, J. K., Arnold, J. J., Cameron, C. E., & Andino, R. (2006) · Nature · doi:10.1038/nature04388 · Cited by 1,116 · cited 2×
“the targets of evolutionary selection [22], and indeed, complementation between members in the quasispecies has been demonstrated in PV-infected mice [23].”
BackgroundQuasispecies Theory and the Behavior of RNA Viruses
Lauring, A. S., & Andino, R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001005 · Cited by 846
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600 · cited 22×
“Nevertheless, recombination in the PV capsid proteins VP1 and VP2 has been sometimes found [42–48].”
BackgroundInfluentialTyping of Human Enteroviruses by Partial Sequencing of VP1
Oberste, M. S., Maher, K., Kilpatrick, D. R., Flemister, M. R., Brown, B. A., & Pallansch, M. A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.5.1288-1293.1999 · Cited by 589
The mechanism of RNA recombination in poliovirus
Kirkegaard, K., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90600-8 · Cited by 501
Basic concepts in RNA virus evolution
Domingo, E., Escarmís, C., Sevilla, N., Moya, A., Elena, S. F., Quer, J., Novella, I. S., & Holland, J. J. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.8.8666162 · Cited by 451
From Emergence to Eradication: The Epidemiology of Poliomyelitis Deconstructed
Nathanson, N., & Kew, O. M. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq320 · Cited by 404
Increased Fidelity Reduces Poliovirus Fitness and Virulence under Selective Pressure in Mice
Pfeiffer, J. K., & Kirkegaard, K. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010011 · Cited by 383
Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis
Ren, R., Costantini, F., Gorgacz, E. J., Lee, J. J., & Racaniello, V. R. (1990) · Cell · doi:10.1016/0092-8674(90)90168-e · Cited by 379
Eigen, M. (1993) · Scientific American · doi:10.1038/scientificamerican0793-42 · Cited by 313
Transgenic mice susceptible to poliovirus.
Koike, S., Taya, C., Kurata, T., Abe, S., Ise, I., Yonekawa, H., & Nomoto, A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.951 · Cited by 294
Engineering attenuated virus vaccines by controlling replication fidelity
Vignuzzi, M., Wendt, E., & Andino, R. (2008) · Nature Medicine · doi:10.1038/nm1726 · Cited by 282
Frequency and Dynamics of Recombination within Different Species of Human Enteroviruses
Simmonds, P., & Welch, J. (2006) · Journal of Virology · doi:10.1128/jvi.80.1.483-493.2006 · Cited by 269
Genetic recombination with newcastle disease virus, polioviruses, and influenza
Hirst, G. K. (1962) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1962.027.001.028 · Cited by 269
Evidence of recombination among enteroviruses
Santti, J., Hyypiä, T., Kinnunen, L., & Salminen, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8741-8749.1999 · Cited by 259 · cited 1×
“Recombination between viral RNA genomes is a well-known phenomenon for enteroviruses [28–31].”
BackgroundBrown, B., Oberste, M. S., Maher, K., & Pallansch, M. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8973-8984.2003 · Cited by 238
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H., Shimizu, H., Yoneyama, T., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8366-8377.2003 · Cited by 233
Role of recombination in evolution of enteroviruses
Lukashev, A. N. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.457 · Cited by 224
The Alpha/Beta Interferon Response Controls Tissue Tropism and Pathogenicity of Poliovirus
Ida-Hosonuma, M., Iwasaki, T., Yoshikawa, T., Nagata, N., Sato, Y., Sata, T., Yoneyama, M., Fujita, T., Taya, C., Yonekawa, H., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.4460-4469.2005 · Cited by 219
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient
Kew, O. M., Sutter, R. W., Nottay, B. K., McDonough, M. J., Prevots, D. R., Quick, L., & Pallansch, M. A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.2893-2899.1998 · Cited by 213 · cited 1×
“19 years, respectively (10% and 18% nt sequence divergence, respectively) [71,72].”
Molecular strategy for ‘serotyping’ of human enteroviruses
Caro, V., Guillot, S., Delpeyroux, F., & Crainic, R. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-1-79 · Cited by 211
Self-citationSimmonds, P. (2006) · Journal of Virology · doi:10.1128/jvi.01076-06 · Cited by 204 · cited 2×
“The enterovirus capsid, rarely subject to recombination [31], appears as the main viral structure that determines virus types.”
BackgroundNatural genetic exchanges between vaccine and wild poliovirus strains in humans.
Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert-Combiescu, A., Delpeyroux, F., & Crainic, R. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8434-8443.2000 · Cited by 202
Self-citationBiebricher, C. K., & Eigen, M. (2005) · Virus Research · doi:10.1016/j.virusres.2004.11.002 · Cited by 196
Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range
Jorba, J., Campagnoli, R., De, L., & Kew, O. (2008) · Journal of Virology · doi:10.1128/jvi.02354-07 · Cited by 177
Recombination in circulating enteroviruses
Lukashev, A. N., Lashkevich, V. A., Ivanova, O. E., Koroleva, G. A., Hinkkanen, A. E., & Ilonen, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10423-10431.2003 · Cited by 170 · cited 1×
“Overall, recombination among enteroviruses is frequent [40] and Lukashev and colleagues [28] proposed that enterovirus species consist of a finite set of capsid genes responsible for different serotypes and a continuum of nonstructural protein genes that seem to evolve in a relatively”
BackgroundAlexander, J. P., Gary, H. E., & Pallansch, M. A. (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.supplement_1.s176 · Cited by 170 · cited 1×
“This implies that VDPVs had been circulating or multiplying for more than one year, which is far beyond the normal average period of multiplication of OPV in vaccinees, rarely exceeding eight weeks [69].”
BackgroundGenetic recombination with poliovirus type 1
Ledinko, N. (1963) · Virology · doi:10.1016/0042-6822(63)90145-4 · Cited by 163 · cited 1×
“Recombination has been known to occur in the poliovirus (PV) genome for almost fifty years [1,2] and this virus has been used as a model to investigate recombination molecular mechanisms in single stranded RNA genomes of positive polarity.”
MethodMacLennan, C., Dunn, G., Huissoon, A. P., Kumararatne, D. S., Martin, J., O'Leary, P., Thompson, R. A., Osman, H., Wood, P., Minor, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16150-3 · Cited by 162
Martín, J., Dunn, G., Hull, R., Patel, V., & Minor, P. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3001-3010.2000 · Cited by 160 · cited 1×
“immunodeficiencies, in particular hypogammaglobulinemia [65].”
Furlone, M., Guillot, S., Otelea, D., Balanant, J., Candrea, A., & Crainic, R. (1993) · Virology · doi:10.1006/viro.1993.1468 · Cited by 148 · cited 9×
“This could be the cause of very rare cases (1 case per 0.2–2.5 million OPV doses) of vaccine-associated paralytic poliomyelitis (VAPP), which is clinically indistinguishable from poliomyelitis caused by wild-type PV.”
BackgroundInfluentialCirculation of type 1 vaccine-derived poliovirus in the philippines in 2001
Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13512-13521.2004 · Cited by 146
Liu, Y., Wang, C., Mueller, S., Paul, A. V., Wimmer, E., & Jiang, P. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001066 · Cited by 142
Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine
Bouchard, M. J., Lam, D. H., & Racaniello, V. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4972-4978.1995 · Cited by 140 · cited 16×
“Nevertheless, recombination in the PV capsid proteins VP1 and VP2 has been sometimes found [42–48].”
BackgroundInfluentialRecombinant Vaccine–Derived Poliovirus in Madagascar
Rousset, D., Rakoto-Andrianarivelo, M., Razafindratsimandresy, R., Randriamanalina, B., Guillot, S., Balanant, J., Mauclère, P., & Delpeyroux, F. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0907.020692 · Cited by 138 · cited 2×
“In Madagascar, an outbreak occurred in the southern province of Toliara, between October 2001 and April 2002, where the last wild-type PV had been reported in October 1997 [87].”
BackgroundSelf-citationGavrilin, G. V., Cherkasova, E. A., Lipskaya, G. Y., Kew, O. M., & Agol, V. I. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7381-7390.2000 · Cited by 138
Genomic Features of Intertypic Recombinant Sabin Poliovirus Strains Excreted by Primary Vaccinees
Cuervo, N. S., Guillot, S., Romanenkova, N., Combiescu, M., Aubert-Combiescu, A., Seghier, M., Caro, V., Crainic, R., & Delpeyroux, F. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.5740-5751.2001 · Cited by 136 · cited 1×
“However, sequences of Sabin type 1 origin are regularly found in S2/S1 and S3/S1 recombinant strains [57].”
BackgroundSelf-citationImplications of a circulating vaccine-derived poliovirus in Nigeria
Jenkins, H. E., Aylward, R. B., Gasasira, A., Donnelly, C. A., Mwanza, M., Corander, J., Garnier, S., Chauvin, C., Abanida, E., Pate, M. A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910074 · Cited by 131
Romanova, L. I., Blinov, V. M., Tolskaya, E. A., Viktorova, E. G., Kolesnikova, M. S., Guseva, E. A., & Agol, V. I. (1986) · Virology · doi:10.1016/0042-6822(86)90180-7 · Cited by 128
Nonreplicative RNA Recombination in Poliovirus
Gmyl, A. P., Belousov, E. V., Maslova, S. V., Khitrina, E. V., Chetverin, A. B., & Agol, V. I. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.8958-8965.1999 · Cited by 128
Wassilak, S., Pate, M. A., Wannemuehler, K., Jenks, J., Burns, C., Chenoweth, P., Abanida, E. A., Adu, F., Baba, M., Gasasira, A., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq140 · Cited by 120
Liu, H.-M., Zheng, D.-P., Zhang, L.-B., Oberste, M. S., Pallansch, M. A., & Kew, O. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11153-11161.2000 · Cited by 119 · cited 1×
“also been identified in type 1 wild/vaccine recombinant PV sharing a 367 nt block of Sabin 1-derived sequence spanning the VP1 and 2A genes that circulated in China from 1991 to 1993 [42,62].”
BackgroundDirect measurement of the poliovirus RNA polymerase error frequency in vitro
Ward, C. D., Stokes, M. A., & Flanegan, J. B. (1988) · Journal of Virology · doi:10.1128/jvi.62.2.558-562.1988 · Cited by 118 · cited 2×
“As mentioned above, the rate of PV evolution is extremely high and mainly due to the high frequency of nt misincorporation in RNA synthesis, [15].”
BackgroundJegouic, S., Joffret, M.-L., Blanchard, C., Riquet, F. B., Perret, C., Pelletier, I., Colbere-Garapin, F., Rakoto-Andrianarivelo, M., & Delpeyroux, F. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000412 · Cited by 116
Self-citationMechanism of Injury-Provoked Poliomyelitis
Gromeier, M., & Wimmer, E. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5056-5060.1998 · Cited by 110
Georgescu, M. M., Delpeyroux, F., Tardy-Panit, M., Balanant, J., Combiescu, M., Combiescu, A. A., Guillot, S., & Crainic, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8089-8101.1994 · Cited by 109
Self-citationShulman, L. M., Manor, Y., Handsher, R., Delpeyroux, F., McDonough, M. J., Halmut, T., Silberstein, I., Alfandari, J., Quay, J., Fisher, T., et al. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.10.3729-3734.2000 · Cited by 109
Self-citationYang, C.-F., Chen, H.-Y., Jorba, J., Sun, H.-C., Yang, S.-J., Lee, H.-C., Huang, Y.-C., Lin, T.-Y., Chen, P.-J., Shimizu, H., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12623-12634.2005 · Cited by 106
Jiang, P., Faase, J. A. J., Toyoda, H., Paul, A., Wimmer, E., & Gorbalenya, A. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700451104 · Cited by 105
Natural genetic recombination between co-circulating heterotypic enteroviruses
Oprisan, G., Combiescu, M., Guillot, S., Caro, V., Combiescu, A., Delpeyroux, F., & Crainic, R. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-9-2193 · Cited by 105 · cited 1×
“Recombination between viral RNA genomes is a well-known phenomenon for enteroviruses [28–31].”
BackgroundSelf-citationBlomqvist, S., Savolainen, C., Laine, P., Hirttiö, P., Lamminsalo, E., Penttilä, E., Jöks, S., Roivainen, M., & Hovi, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4876-4883.2004 · Cited by 104
Long-term circulation of vaccine-derived poliovirus that causes paralytic disease
Cherkasova, E. A., Korotkova, E. A., Yakovenko, M. L., Ivanova, O. E., Eremeeva, T. P., Chumakov, K. M., & Agol, V. I. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6791-6799.2002 · Cited by 103
Cherkasova, E., Laassri, M., Chizhikov, V., Korotkova, E., Dragunsky, E., Agol, V. I., & Chumakov, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633511100 · Cited by 101 · cited 2×
“Microarray analysis has been proposed to monitor the evolution of such highly divergent VDPVs [26].”
BackgroundReemergence of recombinant vaccine–derived poliovirus outbreak in Madagascar.
Rakoto‐Andrianarivelo, M., Gumede, N., Jegouic, S., Balanant, J., Andriamamonjy, S. N., Rabemanantsoa, S., Birmingham, M., Randriamanalina, B., Nkolomoni, L., Venter, M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/587694 · Cited by 100
Self-citationTransmission of Imported Vaccine‐Derived Poliovirus in an Undervaccinated Community in Minnesota
Alexander, J. P., Ehresmann, K., Seward, J., Wax, G., Harriman, K., Fuller, S., Cebelinski, E. A., Chen, Q., Jorba, J., Kew, O. M., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/596052 · Cited by 99
Nonreplicative homologous RNA recombination: Promiscuous joining of RNA pieces?
GMYL, A. P., KORSHENKO, S. A., BELOUSOV, E. V., KHITRINA, E. V., & AGOL, V. I. (2003) · RNA · doi:10.1261/rna.5111803 · Cited by 97
Lipskaya, G. Y., Muzychenko, A. R., Kutitova, O. K., Maslova, S. V., Equestre, M., Drozdov, S. G., Bercoff, R. P., & Agol, V. I. (1991) · Journal of Medical Virology · doi:10.1002/jmv.1890350415 · Cited by 97
Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar
Rakoto-Andrianarivelo, M., Guillot, S., Iber, J., Balanant, J., Blondel, B., Riquet, F., Martin, J., Kew, O., Randriamanalina, B., Razafinimpiasa, L., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030191 · Cited by 96 · cited 3×
“Most of them showed the 3'-half of their genome derived from non-OPV sequences with recombination sites located in proteins 2A or 2B [67,83,84,88].”
BackgroundSelf-citationArita, M., Zhu, S.-L., Yoshida, H., Yoneyama, T., Miyamura, T., & Shimizu, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12650-12657.2005 · Cited by 95 · cited 2×
“However, OPV/HEV-C recombinants were also isolated in countries (Hispaniola, Philippines, Cambodia and Madagascar) in which wild PVs had been eradicated [83,84,88,89,94].”
BackgroundBlomqvist, S., Bruu, A.-L., Stenvik, M., & Hovi, T. (2003) · Journal of General Virology · doi:10.1099/vir.0.18708-0 · Cited by 94
Serial Recombination during Circulation of Type 1 Wild-Vaccine Recombinant Polioviruses in China
Liu, H.-M., Zheng, D.-P., Zhang, L.-B., Oberste, M. S., Kew, O. M., & Pallansch, M. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.10994-11005.2003 · Cited by 88
An Outbreak of Poliomyelitis Caused by Type 1 Vaccine‐Derived Poliovirus in China
Liang, X., Zhang, Y., Xu, W., Wen, N., Zuo, S., Lee, L. A., & Yu, J. (2006) · The Journal of Infectious Diseases · doi:10.1086/506359 · Cited by 87
Martín, J., Samoilovich, E., Dunn, G., Lackenby, A., Feldman, E., Heath, A., Svirchevskaya, E., Cooper, G., Yermalovich, M., & Minor, P. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10921-10928.2002 · Cited by 86
Tolskaya, E. A., Romanova, L. I., Blinov, V. M., Viktorova, E. G., Sinyakov, A. N., Kolesnikova, M. S., & Agol, V. I. (1987) · Virology · doi:10.1016/0042-6822(87)90170-x · Cited by 81
Neurovirulent Vaccine-Derived Polioviruses in Sewage from Highly Immune Populations
Shulman, L. M., Manor, Y., Sofer, D., Handsher, R., Swartz, T. A., Delpeyroux, F., & Mendelson, E. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000069 · Cited by 77
Self-citationA Large Vaccine‐Derived Poliovirus Outbreak on Madura Island—Indonesia, 2005
Estívariz, C. F., Watkins, M. A., Handoko, D., Rusipah, R., Deshpande, J., Rana, B. J., Irawan, E., Widhiastuti, D., Pallansch, M. A., Thapa, A., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/525049 · Cited by 77
King, A. M. Q. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.24.11705 · Cited by 75
Vaccine-derived poliovirus from long term excretors and the end game of polio eradication
Martín, J. E.-S. (2006) · Biologicals · doi:10.1016/j.biologicals.2006.02.005 · Cited by 74
Ohka, S., Igarashi, H., Nagata, N., Sakai, M., Koike, S., Nochi, T., Kiyono, H., & Nomoto, A. (2007) · Journal of Virology · doi:10.1128/jvi.02675-06 · Cited by 74
Molecular Mechanisms of Poliovirus Variation and Evolution
Agol, V. I. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-26397-7_8 · Cited by 73
Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis
Buttinelli, G., Donati, V., Fiore, S., Marturano, J., Plebani, A., Balestri, P., Soresina, A. R., Vivarelli, R., Delpeyroux, F., Martin, J., et al. (2003) · Journal of General Virology · doi:10.1099/vir.0.18974-0 · Cited by 73
Self-citationKorotkova, E. A., Park, R., Cherkasova, E. A., Lipskaya, G. Y., Chumakov, K. M., Feldman, E. V., Kew, O. M., & Agol, V. I. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12460-12465.2003 · Cited by 73 · cited 1×
“Suspicion of long-term circulation was also inferred from the analysis of divergent OPV strains isolated from patients with AFP in the Russian Federation [26,52,100] or from non-immunized populations in Byelorussia [101].”
BackgroundIsolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child
Adu, F., Iber, J. C., Bukbuk, D. N., Gumede, N., Yang, S.-J., Jorba, J. C., Campagnoli, R. P., Sule, W. F., Yang, C.-F., Burns, C. C., et al. (2007) · Virus Research · doi:10.1016/j.virusres.2007.03.009 · Cited by 70
A model for rearrangements in RNA genomes
Pilipenko, E. V., Gmyl, A. P., & Agol, V. I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.11.1870 · Cited by 70
Mechanisms of genetic variation in polioviruses
Savolainen‐Kopra, C., & Blomqvist, S. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.663 · Cited by 67
Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus
Georgescu, M.-M., Delpeyroux, F., & Crainic, R. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-9-2343 · Cited by 64
Self-citationDetermination of the poliovirus RNA polymerase error frequency at eight sites in the viral genome
Ward, C. D., & Flanegan, J. B. (1992) · Journal of Virology · doi:10.1128/jvi.66.6.3784-3793.1992 · Cited by 63
Genetic recombination in wild-type poliovirus
Dahourou, G., Guillot, S., Le Gall, O., & Crainic, R. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-12-3103 · Cited by 63
Lancaster, K. Z., & Pfeiffer, J. K. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000791 · Cited by 63
Yakovenko, M. L., Cherkasova, E. A., Rezapkin, G. V., Ivanova, O. E., Ivanov, A. P., Eremeeva, T. P., Baykova, O. Y., Chumakov, K. M., & Agol, V. I. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.2641-2653.2006 · Cited by 62
Receptor-Dependent and -Independent Axonal Retrograde Transport of Poliovirus in Motor Neurons
Ohka, S., Sakai, M., Bohnert, S., Igarashi, H., Deinhardt, K., Schiavo, G., & Nomoto, A. (2009) · Journal of Virology · doi:10.1128/jvi.02225-08 · Cited by 58
Genetic Relationship between Cocirculating Human Enteroviruses Species C
Bessaud, M., Joffret, M.-L., Holmblat, B., Razafindratsimandresy, R., & Delpeyroux, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024823 · Cited by 55
Self-citationRoivainen, M., Blomqvist, S., Al‐Hello, H., Paananen, A., Delpeyroux, F., Kuusi, M., & Hovi, T. (2010) · Eurosurveillance · doi:10.2807/ese.15.19.19566-en · Cited by 54
Self-citationHigh Frequency of Human Enterovirus Species C Circulation in Madagascar
Rakoto-Andrianarivelo, M., Rousset, D., Razafindratsimandresy, R., Chevaliez, S., Guillot, S., Balanant, J., & Delpeyroux, F. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.242-249.2005 · Cited by 53
Self-citationMueller, J. E., Bessaud, M., Huang, Q. S., Martínez, L. C., Barril, P. A., Morel, V., Balanant, J., Bocacao, J., Hewitt, J., Gessner, B. D., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.02201-08 · Cited by 48
Self-citationSabin Type 2 Polioviruses with Intertypic Vaccine/Vaccine Recombinant Genomes
Georgopoulou, A., & Markoulatos, P. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960100610 · Cited by 46
Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant
Dedepsidis, E., Pliaka, V., Kyriakopoulou, Z., Brakoulias, C., Levidiotou-Stefanou, S., Pratti, A., Mamuris, Z., & Markoulatos, P. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00381.x · Cited by 45
Joffret, M.-L., Jégouic, S., Bessaud, M., Balanant, J., Tran, C., Caro, V., Holmblat, B., Razafindratsimandresy, R., Reynes, J.-M., Rakoto-Andrianarivelo, M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis204 · Cited by 44
Self-citationOdoom, J. K., Yunus, Z., Dunn, G., Minor, P. D., & Martín, J. (2008) · Journal of Virology · doi:10.1128/jvi.00468-08 · Cited by 43
Isolation of vaccine-derived polioviruses in the Slovak Republic
Cernakova, B., Sobotová, Z., Rovný, I., Blahova, S., Roivainen, M., & Hovi, T. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1331-9 · Cited by 36
Zhang, Y., Zhu, S., Yan, D., Liu, G., Bai, R., Wang, D., Chen, L., Zhu, H., An, H., Kew, O. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015300 · Cited by 35
Prevalence of vaccine-derived polioviruses in sewage and river water in South Africa
Pavlov, D. N., van Zyl, W. B., Heerden, J. V., Grabow, W. O. K., & Ehlers, M. M. (2005) · Water Research · doi:10.1016/j.watres.2005.05.027 · Cited by 33
Evolution of a rare vaccine-derived multirecombinant poliovirus
Karakasiliοtis, I., Paximadi, E., & Markoulatos, P. (2005) · Journal of General Virology · doi:10.1099/vir.0.80823-0 · Cited by 33
Duggal, R., & Wimmer, E. (1999) · Virology · doi:10.1006/viro.1999.9703 · Cited by 32
Riquet, F. B., Blanchard, C., Jegouic, S., Balanant, J., Guillot, S., Vibet, M.-A., Rakoto-Andrianarivelo, M., & Delpeyroux, F. (2008) · Journal of Virology · doi:10.1128/jvi.00239-08 · Cited by 29
Self-citationZhang, Y., Wang, H., Zhu, S., Li, Y., Li, S., Liu, Y., Liu, G., Nishimura, Y., Chen, L., Yan, D., et al. (2009) · Journal of General Virology · doi:10.1099/vir.0.014258-0 · Cited by 26
Blomqvist, S., Savolainen‐Kopra, C., Paananen, A., Bassioni, L. E., Nasr, E. M. E. M., Firstova, L., Zamiatina, N. A., Kutateladze, T., & Roivainen, M. (2010) · Virus Research · doi:10.1016/j.virusres.2010.05.006 · Cited by 25
Horie, H., Yoshida, H., Matsuura, K., Miyazawa, M., Wakabayashi, K., Nomoto, A., & Hashizume, S. (2002) · Journal of Medical Virology · doi:10.1002/jmv.10224 · Cited by 24
Progress toward poliomyelitis eradication - Nigeria, January 2009-June 2010.
(2010) · PubMed · Cited by 22
(2004) · doi:10.1128/isbn978-1-55581-603-2 · Cited by 20
Kyriakopoulou, Z., Kottaridi, C., Dedepsidis, E., Bolanaki, E., Levidiotou-Stefanou, S., & Markoulatos, P. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.3.1150-1152.2006 · Cited by 20
Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania
Combiescu, M., Guillot, S., Persu, A., Băicuş, A., Pițigoi, D., Balanant, J., Oprişan, G., Crainic, R., Delpeyroux, F., & Aubert-Combiescu, A. (2007) · Archives of Virology · doi:10.1007/s00705-006-0884-y · Cited by 19
Self-citationRomanenkova, N. I., Guillot, S., Rozaeva, N. R., Crainic, R., Bichurina, M. A., & Delpeyroux, F. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00017-06 · Cited by 16
Self-citationGlobal update on vaccine-derived polioviruses, January 2006-August 2007.
(2007) · PubMed · Cited by 14
Acute flaccid paralysis associated with circulating vaccine-derived poliovirus, Philippines, 2001.
(2001) · PubMed · Cited by 13
Polio Outbreak Breaks the Rules
Roberts, L. (2010) · Science · doi:10.1126/science.330.6012.1730 · Cited by 12
Băicuş, A., Persu, A., Dinu, S., Joffret, M., Delpeyroux, F., & Oprişan, G. (2011) · Archives of Virology · doi:10.1007/s00705-010-0895-6 · Cited by 9
Self-citationPicornaviruses as a Model for Studying the Nature of RNA Recombination
Agol, V. I. (2014) · ASM Press eBooks · doi:10.1128/9781555816698.ch15 · Cited by 9
Vaccine-derived polioviruses--update.
(2006) · PubMed · Cited by 8
Surveillance of Poliovirus-Isolates in Japan, 2001
Yoneyama, T., Sasagawa, A., Kikuchi, M., Noda, N., Shinkawa, N., Yoshida, K., & Miyamura, T. (2002) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2002.57 · Cited by 3
Surveillance of Poliovirus-Isolates in Japan, 2000
Yoneyama, T., Sakae, K., Baba, J., Nakayama, T., Chijiwa, K., Kizoe, K., Shimizu, H., Iizuka, S., lshizaki, T., Kondo, R., et al. (2001) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2001.80 · Cited by 3
Research works printed but not linked: 1
- Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., and Martin, M.A. (2007). Fields Virology, Wolters Kluwer Health/Lippincott Williams & Wilkins. [5th ed.].
Cited by
Recombination in viruses: Mechanisms, methods of study, and evolutionary consequences
Pérez-Losada, M., Arenas, M., Galán, J. C., Palero, F., & González-Candelas, F. (2015) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2014.12.022 · Cited by 450
Recombination in Enteroviruses, a Multi-Step Modular Evolutionary Process
Muslin, C., Kain, A. M., Bessaud, M., Blondel, B., & Delpeyroux, F. (2019) · Viruses · doi:10.3390/v11090859 · Cited by 142
Self-citationBessaud, M., Razafindratsimandresy, R., Nougaırède, A., Joffret, M., Deshpande, J. M., Dubot‐Pérès, A., Héraud, J., de Lamballerie, X. N., Delpeyroux, F., & Bailly, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090624 · Cited by 136
Self-citationHigh Frequency and Diversity of Species C Enteroviruses in Cameroon and Neighboring Countries
Sadeuh-Mba, S. A., Bessaud, M., Massenet, D., Joffret, M.-L., Endegue, M.-C., Njouom, R., Reynes, J.-M., Rousset, D., & Delpeyroux, F. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02119-12 · Cited by 108
Self-citationTebbens, R. J. D., Pallansch, M. A., Kim, J., Burns, C. C., Kew, O. M., Oberste, M. S., Diop, O. M., Wassilak, S. G. F., Cochi, S. L., & Thompson, K. M. (2013) · Risk Analysis · doi:10.1111/risa.12022 · Cited by 105
Metadata
- Authors
- Combelas, N., Holmblat, B., Joffret, M.-L., Colbère-Garapin, F., & Delpeyroux, F.
- Affiliations
- Inserm (FR)
- Biologie des Virus Entériques, Institut Pasteur, 75724 Paris-cedex 15, France
- ORCID
- Joffret, Marie-Line
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2011-08-17
- Volume
- 3
- Issue
- 8
- Pages
- 1460-1484
- ISSN
- 1999-4915 (ISSN-L)
- PMC
- PMC3185806
- OpenAlex
- W1996701485
- Semantic Scholar
- d3ccac6fa304ec7b1eb2b3f77e673e996fd1d00b
- Cited by
- 135
- References
- 114
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 10 · 2020: 9 · 2019: 10 · 2018: 12 · 2017: 5 · 2016: 11 · 2015: 10 · 2014: 16 · 2013: 15 · 2012: 8
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Viruses (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Agence Nationale de la Recherche
- Fondation pour la Recherche Médicale (DMI20091117313, FRM DMI20091117313)
- Fondation Mérieux
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- genetic recombination, poliovirus, viral emergence, mosaic genomes, viral evolution, poliomyelitis outbreak, viral diversity, intertypic recombination
- MeSH terms
- Coxsackievirus Infections, Humans, Models, Genetic, Mutation, Poliomyelitis, Recombination, Genetic, RNA, Viral, Species Specificity, Genome, Viral, Poliovirus, Evolution, Molecular, Poliovirus Vaccines, Enterovirus C, Human, Genomic Instability, Disease Eradication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.